Improved Amino Acid, Bioenergetic Metabolite and Neurotransmitter Profiles following Human Amnion Epithelial Cell Transplant in Intermediate Maple Syrup Urine Disease Mice
- 30 June 2013
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 109 (2), 132-138
- https://doi.org/10.1016/j.ymgme.2013.02.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Placental stem cell correction of murine intermediate maple syrup urine diseaseHepatology, 2012
- Amniotic membrane: from structure and functions to clinical applicationsCell and tissue research, 2012
- Hepatic differentiation of amniotic epithelial cellsHepatology, 2011
- Hepatocyte transplantation for correction of inborn errors of metabolismCurrent Opinion in Nephrology and Hypertension, 2009
- Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Hepatocyte Transplantation Improves Phenotype and Extends Survival in a Murine Model of Intermediate Maple Syrup Urine DiseaseMolecular Therapy, 2009
- Animal models of maple syrup urine diseaseJournal of Inherited Metabolic Disease, 2009
- Dual mechanism of brain injury and novel treatment strategy in maple syrup urine diseaseBrain, 2008
- α-Ketoisocaproate Alters the Production of Both Lactate and Aspartate from [U-13C]Glutamate in Astrocytes: A 13C NMR StudyJournal of Neurochemistry, 2002
- Myelin proteins: Degradation in rat brain initiated by metabolites causative of maple syrup urine diseaseBiochemical and Biophysical Research Communications, 1983